Literature DB >> 11127535

A prevalence study of primary dystonia in eight European countries.

.   

Abstract

There have been few epidemiological studies of dystonia. Most previous studies have provided estimates based on few cases. A European prevalence study was undertaken to provide more precise rates of dystonia by pooling data from eight European countries. Diagnosed cases were ascertained by adult neurologists with specialist movement disorder (and botulinum toxin) clinics. The crude annual period prevalence rate (1996-1997) for primary dystonia was 152 per million (95% confidence interval 142-162), with focal dystonia having the highest rate of 117 per million (108-126). Prevalence rates for cervical dystonia, blepharospasm and writer's cramp were as follows: 57 (95% confidence interval 51-63), 36 (31-41), and 14 (11-17). The age-adjusted relative rates were significantly higher in women than in men for segmental and focal dystonias with the exception of writer's cramp. Comparing rates between centres demonstrated significant variations for cervical dystonia, blepharospasm and writer's cramp, probably due to methodological differences. Our results provide the first data on the prevalence of primary dystonia and its subtypes across several European countries. Due to under-ascertainment of cases, our rates should be seen as conservative and an under-estimate of the true prevalence of dystonia.

Entities:  

Mesh:

Year:  2000        PMID: 11127535     DOI: 10.1007/s004150070094

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  81 in total

1.  [The application of botulinum toxin in oromandibular, pharyngeal and laryngeal dystonia].

Authors:  A Olthoff; R Laskawi
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  "Visual sensory trick" in patient with cervical dystonia.

Authors:  Chan-Nyoung Lee; Mi-Yeon Eun; Do-Young Kwon; Moon Ho Park; Kun-Woo Park
Journal:  Neurol Sci       Date:  2011-11-10       Impact factor: 3.307

Review 3.  Genetic and clinical features of primary torsion dystonia.

Authors:  Laurie J Ozelius; Susan B Bressman
Journal:  Neurobiol Dis       Date:  2010-12-17       Impact factor: 5.996

Review 4.  Botulinum toxin type A versus anticholinergics for cervical dystonia.

Authors:  J Costa; C Espírito-Santo; A Borges; J J Ferreira; M Coelho; C Sampaio
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

5.  Cervical dystonia as first manifestation of multiple sclerosis.

Authors:  Stephan J Rüegg; Manuela Bühlmann; Susanne Renaud; Andreas J Steck; Ludwig Kappos; Peter Fuhr
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

6.  Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up.

Authors:  J J M Kruisdijk; J H T M Koelman; B W Ongerboer de Visser; R J de Haan; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-21       Impact factor: 10.154

Review 7.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

8.  Excessive blinking as an initial manifestation of juvenile Huntington's disease.

Authors:  Shihui Xing; Ling Chen; Xi Chen; Zhong Pei; Jinsheng Zeng; Jinru Li
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

Review 9.  Task-specific dystonias: a review.

Authors:  Diego Torres-Russotto; Joel S Perlmutter
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 10.  Dystonia.

Authors:  Ailsa Snaith; Derick Wade
Journal:  BMJ Clin Evid       Date:  2008-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.